Logo image
SIRT2 suppresses aging-associated cGAS activation and protects aged mice from severe COVID-19
Journal article   Open access   Peer reviewed

SIRT2 suppresses aging-associated cGAS activation and protects aged mice from severe COVID-19

Marine Barthez, Biyun Xue, Jian Zheng, Yifei Wang, Zehan Song, Wei-Chieh Mu, Chih-ling Wang, Jiayue Guo, Fanghan Yang, Yuze Ma, …
Cell reports (Cambridge), Vol.44(4), 115562
04/11/2025
DOI: 10.1016/j.celrep.2025.115562
PMCID: PMC12074670
PMID: 40220296
url
https://doi.org/10.1016/j.celrep.2025.115562View
Published (Version of record) Open Access

Abstract

Aging-associated vulnerability to coronavirus disease 2019 (COVID-19) remains poorly understood. Here, we show that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected aged mice lacking SIRT2, a cytosolic NAD+-dependent deacetylase, develop more severe disease and show increased mortality, while treatment with an NAD+ booster, 78c, protects aged mice from lethal infection. Mechanistically, we demonstrate that SIRT2 modulates the acetylation of cyclic GMP-AMP synthase (cGAS), an immune sensor for cytosolic DNA, and suppresses aging-associated cGAS activation and inflammation. Furthermore, we show that SARS-CoV-2 infection-induced inflammation is mediated at least in part by ORF3a, which triggers mtDNA release and cGAS activation. Collectively, our study reveals a molecular basis for aging-associated susceptibility to COVID-19 and suggests therapeutic approaches to protect aged populations from severe SARS-CoV-2 infection. [Display omitted] •SIRT2 and NAD+ boosting protect against aging-associated severe COVID-19•SARS-CoV-2 ORF3a induces mitochondrial DNA release, cGAS activation, and inflammation•SIRT2 deacetylates cGAS and inhibits aging-associated cGAS activation and inflammation Barthez et al. show that SIRT2 and NAD+ boosting protect against aging-associated severe COVID-19. SARS-CoV-2-induced inflammation is mediated by ORF3a, which triggers mtDNA release and cGAS activation. SIRT2 deacetylates cGAS and suppresses aging-associated cGAS activation and inflammation. This study has implications for protecting aged populations from severe SARS-CoV-2 infection.
Aging Inflammation cGAS COVID-19 mitochondria NAD ORF3a SARS-CoV-2 SIRT1 SIRT2 SIRT3 SIRT6 SIRT7 sirtuin

Details

Logo image